Drug Profile
Research programme: galanin receptor antagonists - Xenome
Alternative Names: GALA research programmeLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Flinders University
- Developer Xenome
- Class Peptides
- Mechanism of Action Galanin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pancreatitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pancreatitis in Australia